Últimas notícias Covishield

As vacinas seguem agora para o Controle de Qualidade interno de Bio-Manguinhos, onde uma análise minuciosa irá garantir a sua integridade e segurança (foto: Bio-Manguinhos/Fiocruz)

Fiocruz plant for Covishield vaccine production undergoes inspection

“The inspection is a key step in making the entire production of the inoculation viable domestically after the technological transfer," Fiocruz states in a note.

Vacina de Oxford/AstraZeneca

Brazil regulator urges use of Covishield jab to continue

In an updated statement on the monitoring of adverse events linked to the use of the vaccine, Anvisa concludes that “the data do not indicate any change in the benefit–risk balance of the vaccine.”

Vacinação drive-thru contra a covid-19 no Parque da Cidade, em Brasília.

National watchdog says vaccines used in Brazil are safe

The public data on the use of vaccines against COVID-19 in the country has thus far shown no link between the inoculation and adverse effects or deaths. No change in the risk–benefit ratio has been reported, Anvisa stated.

  • Load more